2015
DOI: 10.1016/j.mrrev.2014.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of mechanisms driving non-linear dose–response relationships in genotoxicity testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(29 citation statements)
references
References 189 publications
0
29
0
Order By: Relevance
“…One common element across these cases is generation of data to support a hypothesized or demonstrated MOA, a framework with less detailed description than that required for establishing mechanism, based on identification of key events responsible for the observed effects [36]. There are many well-understood biological processes that could underpin a non-linear/bilinear dose-response for genotoxic effects that include DNA repair processes, redundancy in the genetic code, non-coding regions of DNA, processes associated with DNA replication and damage tolerance, DNA damage response networks, and apoptosis/cell death [11, 13, 30]. For DNA alkylating agents, the involvement of certain DNA repair systems, such as BER, HR, Direct Repair, and MMR, shifts the dose-response curve for genotoxic endpoints.…”
Section: New Methods To Investigate Responses At Low-dose Exposuresmentioning
confidence: 99%
See 1 more Smart Citation
“…One common element across these cases is generation of data to support a hypothesized or demonstrated MOA, a framework with less detailed description than that required for establishing mechanism, based on identification of key events responsible for the observed effects [36]. There are many well-understood biological processes that could underpin a non-linear/bilinear dose-response for genotoxic effects that include DNA repair processes, redundancy in the genetic code, non-coding regions of DNA, processes associated with DNA replication and damage tolerance, DNA damage response networks, and apoptosis/cell death [11, 13, 30]. For DNA alkylating agents, the involvement of certain DNA repair systems, such as BER, HR, Direct Repair, and MMR, shifts the dose-response curve for genotoxic endpoints.…”
Section: New Methods To Investigate Responses At Low-dose Exposuresmentioning
confidence: 99%
“…Under normal conditions, the steady state level of endogenous DNA damage was recently estimated at ≥50,000 lesions per cell; the non-instructional and pro-mutagenic abasic sites are the most common DNA lesions, present daily at ~30,000 nucleoside sites in DNA per cell [18, 22, 24]. DNA repair influences the outcome and dose-response of mutation and chromosome damage following exposure to DNA damaging agents at all exposure levels [11-15]. DNA repair is usually error-free, but there may be rare events where the mis-repair will result in genotoxic outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…As a result, persistent lung injury and inflammation can trigger secondary genotoxicity due to oxidative stress and frustrated phagocytosis of long, rigid fibers or nanotubes. Cell proliferation is triggered in response to lung cell injury as well as by cytokines and growth factors released from inflammatory cells (Colotta et al 2009; Guerard et al 2015). Persistent inflammation, oxidative stress, and epithelial or mesothelial injury and cell proliferation are considered to play important roles in the development of lung cancer and mesothelioma.…”
Section: Hypotheses On the Mechanistic Events Related To Genotoxicitymentioning
confidence: 99%
“…Degradation of ONs by nucleases to mononucleotides could result in a genotoxic event, due to the incorporation of mononucleotides into a newly synthesized DNA strand, which could lead to DNA strand breaks due to chain termination during replication or mis‐pairing and mutation. Such genotoxic mechanisms have been described for nucleoside analogues used as antiviral drugs (Wutzler and Thust, ; Guérard et al, ) and are well detected by the standard genotoxicity tests (S2(R1) June 2011). In the case of current‐generation ONs, due to the (I) slow degradation rate of the parent molecules to mononucleotides, (II) the generally balanced mix of monomers within therapeutic ONs and (III) the fact that most modified nucleotides, resulting from nuclease cleavage of ONs, are poor substrates for endogenous kinases or polymerases, this type of genotoxic event is deemed to be of low toxicological concern in this class (Berman et al, ).…”
Section: Discussionmentioning
confidence: 77%